Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 870 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Birmingham AL, Cullman AL, Huntsville AL, Mobile AL,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting
New

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

for
Androgenetic Alopecia
Location: Birmingham AL, Atlanta GA, Smyrna TN, New Orleans LA,
Sponsor: Pelage Pharmaceuticals, Inc.

Sex: Male

Age: 18 - 55

Code: NCT07819435

Phase 2, Phase 3, Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

for
Atrophic Vaginitis, Vaginal Atrophy,
Location: Birmingham AL, West Columbia SC, Fayetteville NC,
Sponsor: Stratpharma AG

Sex: Female

Age: 18+

Code: NCT05953090

Recruiting

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

for
Atopic Dermatitis
Location: Birmingham AL, North Little Rock AR, Greenville SC,
Sponsor: Pfizer

Sex: All

Age: 2 - 11

Code: NCT06807281

Phase 3, Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Birmingham AL, Columbus GA, Bowling Green KY,
Sponsor: Celldex Therapeutics

Sex: All

Age: 18+

Code: NCT07266402

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

for
Healthy Volunteer, Atopic Dermatitis
Location: Birmingham AL, North Little Rock AR,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07527923

Phase 1, Recruiting

A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

for
Cutaneous Lichen Planus
Location: Birmingham AL, Macon GA, New Orleans LA, Baton Rouge LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07775924

Phase 2, Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Birmingham AL, Montgomery AL, Macon GA, Spartanburg SC,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic,
Location: Birmingham AL, Bryant AR, Clarksville IN,
Sponsor: Apollo Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07599813

Phase 2, Recruiting

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

for
Prurigo Nodularis (PN)
Location: Birmingham AL, Murfreesboro TN, Indianapolis IN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07236099

Phase 2, Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

for
Eczema
Location: Birmingham AL, North Little Rock AR, Greenville SC,
Sponsor: Pfizer

Sex: All

Age: 6 - 11

Code: NCT06807268

Phase 3, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Birmingham AL, Nashville TN, Baton Rouge LA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase 3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase 1, Phase 2, Recruiting

A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

for
Pneumococcal Disease
Location: Birmingham AL, Fayetteville GA, Stockbridge GA,
Sponsor: Pfizer

Sex: All

Age: 18 - 49

Code: NCT07794748

Phase 3, Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

for
Obesity, Overweight, Chronic Weight Management,
Location: Birmingham AL, Ridgeland MS, Union City GA,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654374

Phase 3, Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for
Weight Management
Location: Birmingham AL, Ridgeland MS, Dothan AL, Woodstock GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07667803

Phase 3, Recruiting

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Birmingham AL, Huntsville AL, Ridgeland MS,
Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07340320

Phase 2, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Birmingham AL, Marietta GA, Louisville KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Birmingham AL, Germantown TN, Louisville KY,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Birmingham AL, Nashville TN, Decatur IL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting